← Eichor
Condition: Pediatric Solid Tumor Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Pediatric Solid Tumor

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Romiplostim N01 for Chemotherapy-Induced Thrombocytopenia in Pediatric Cancer Patients
Phase 2 · 1 location(s) · Cancer Institute and Hospital, Chinese Academy of Medical Sc · NCT07043894Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumo
Phase 1/Phase 2 · 71 location(s) · Merck Sharp & Dohme LLC · NCT06395103Study Of Cold Cap Therapy For Prevention of Hairloss in Pediatric Patients Receiving Chemotherapy For Non-Malignant Indi
NA · 1 location(s) · St. Jude Children's Research Hospital · NCT04764357Comprehensive Omics Analysis of Pediatric and Adult Solid Tumors and Establishment of a Repository for Related Biologica
Phase N/A · 5 location(s) · National Cancer Institute (NCI) · NCT01109394Tumor-Lymph Node Mapping
Phase N/A · 1 location(s) · University of Rochester · NCT07054944A Study of the Drug Letermovir as Prevention of Cytomegalovirus Infection After Stem Cell Transplant in Pediatric Patien
Phase 3 · 29 location(s) · Children's Oncology Group · NCT05711667A Study of Repotrectinib in Combination With Chemotherapy in Children and Young Adults With Solid Tumor Cancer
Phase 1/Phase 2 · 1 location(s) · Memorial Sloan Kettering Cancer Center · NCT05004116Brigatinib in Pediatric and Young Adult Patients With ALK+ ALCL, IMT or Other Solid Tumors
Phase 1/Phase 2 · 2 location(s) · Princess Maxima Center for Pediatric Oncology · NCT04925609A Study of Cabozantinib as a Maintenance Agent to Prevent Progression or Recurrence in High-Risk Pediatric Solid Tumors
Phase 2 · 6 location(s) · Nationwide Children's Hospital · NCT05135975Tumor Infiltrating Lymphocyte Therapy for Pediatric High Risk Solid Tumors
Phase 1 · 1 location(s) · H. Lee Moffitt Cancer Center and Research Institute · NCT06047977Targeting Pediatric Brain Tumors and Relapsed/Refractory Solid Tumors With Sodium Glucose Cotransporter 2 Inhibitors (SG
Phase 1 · 1 location(s) · Washington University School of Medicine · NCT05521984Collection and Storage of Tissue Samples From Patients Undergoing Surgery For Suspected Solid Tumors
Phase N/A · 1 location(s) · Wake Forest University Health Sciences · NCT00900471Phase II Study of QLC2519 in Pediatric Solid Tumor Participants
Phase 2 · 1 location(s) · Qilu Pharmaceutical Co., Ltd. · NCT07724756Standardized Nutritional Management of Pediatric Patients With Solid Tumors
NA · 1 location(s) · Children's Hospital of Fudan University · NCT06730204Prospective Evaluation Of Delayed Effects Of Pediatric Car T Cell Therapy
Phase N/A · 6 location(s) · St. Jude Children's Research Hospital · NCT06579469Safety and Efficacy of Cyclophosphamide, Sorafenib, Bevacizumab, and Atezolizumab in Pediatric Solid Tumor Patients
Phase 1/Phase 2 · 2 location(s) · St. Jude Children's Research Hospital · NCT05468359Testing the Safety and Efficacy of the Combination of Two Anti-cancer Drugs, ZEN003694 and Abemaciclib, for Adult and Pe
Phase 1 · 7 location(s) · National Cancer Institute (NCI) · NCT05372640Development and Application of Intervention Program to Improve Mental Health and Quality of Life of Solid Tumor Survivor
NA · 3 location(s) · National Cancer Center, Korea · NCT06969742A Study to Evaluate the Safety and Pharmacokinetics of Eflapegrastim in Pediatric Participants With Solid Tumors or Lymp
Phase 2 · 5 location(s) · Spectrum Pharmaceuticals, Inc · NCT04570423Exercise Program (TEAM Me) for the Improvement of Movement and Mobility in Pediatric and Adolescent and Young Adult Pati
NA · 2 location(s) · M.D. Anderson Cancer Center · NCT04678427Optimal Precision TherapIes to CustoMISE Care in Childhood and Adolescent Cancer
Phase 1/Phase 2 · 14 location(s) · Australian & New Zealand Children's Haematology/Oncology Gro · NCT06208657Next Generation Sequencing of Normal Tissues Prospectively in Pediatric Oncology Patients
Phase N/A · 1 location(s) · St. Jude Children's Research Hospital · NCT02530658Clinical Trial of GAIA-102 for Refractory/Relapse Neuroblastomas and Other Malignant Pediatric Solid Tumors
Phase 1 · 1 location(s) · Kyushu University · NCT05608148A Study of Patritumab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01C/LIGHTBE
Phase 1/Phase 2 · 63 location(s) · Merck Sharp & Dohme LLC · NCT06941272A Phase I, First in Human Study of CBA-1205, Anti-DLK1 Monoclonal Antibody in Patients With Advanced Solid Tumors, Hepat
Phase 1 · 5 location(s) · Chiome Bioscience Inc. · NCT06636435PEEL-224, Vincristine and Temozolomide in Pediatric Solid Tumors
Phase 1/Phase 2 · 7 location(s) · Theodore Laetsch · NCT06721689Biomarkers of Resiliency In Childhood Cancer Surgery
Phase N/A · 1 location(s) · Mayo Clinic · NCT06674811Ex Vivo Drug Sensitivity Testing and Multi-Omics Profiling
Phase 1 · 1 location(s) · Florida International University · NCT05857969Study of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing Sarcoma
Phase 1/Phase 2 · 10 location(s) · St. Jude Children's Research Hospital · NCT04901702Metarrestin (ML-246) in Subjects With Metastatic Solid Tumors
Phase 1 · 2 location(s) · National Cancer Institute (NCI) · NCT04222413
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.